Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
35.07
-1.86 (-5.04%)
At close: Aug 20, 2025, 3:59 PM
35.42
1.00%
After-hours: Aug 20, 2025, 07:43 PM EDT

Caris Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
51.16M 37.94M 35.74M
Depreciation & Amortization
32.88M 29.48M 28.77M
Stock-Based Compensation
566K 593K 540K
Other Working Capital
1.13M 30.85M 33.65M
Other Non-Cash Items
-12.99M -7.44M -22.45M
Deferred Income Tax
4.41M -2.27M -940K
Change in Working Capital
21.6M 27.97M 34.13M
Operating Cash Flow
97.61M 86.28M 75.79M
Capital Expenditures
-545.17M -105.08M -171.65M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
29.82M 21.62M 27.54M
Investing Cash Flow
-515.36M -83.46M -144.11M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a -12.79M
Dividend Paid
-7.41M -7.41M -7.4M
Other Financial Acitivies
436.22M -4.66M 69.82M
Financial Cash Flow
428.81M -12.06M 62.42M
Net Cash Flow
11.08M -9.37M -5.9M
Free Cash Flow
-447.56M -18.8M -95.86M